Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)

被引：0
|
作者：
Francesco Gelsomino
Marcello Tiseo
Fausto Barbieri
Ferdinando Riccardi
Luigi Cavanna
Antonio Frassoldati
Angelo Delmonte
Lucia Longo
Claudio Dazzi
Saverio Cinieri
Ida Colantonio
Francesca Sperandi
Giuseppe Lamberti
Stefano Brocchi
Lorenzo Tofani
Luca Boni
Andrea Ardizzoni
机构：
[1] Policlinico Sant’Orsola-Malpighi,Medical Oncology Unit
[2] Azienda Ospedaliero-Universitaria of Parma,Medical Oncology Unit
[3] Policlinico of Modena,Medical Oncology Unit
[4] Azienda Ospedaliera Cardarelli,Medical Oncology Unit
[5] AUSL of Piacenza,Medical Oncology Unit
[6] Azienda Ospedaliero-Universitaria of Ferrara,Medical Oncology Unit
[7] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,Department of Medical Oncology
[8] AUSL of Modena,Medical Oncology Unit
[9] Hospital of Carpi,Medical Oncology Unit
[10] AUSL of Romagna,Medical Oncology Unit
[11] Hospital of Ravenna,Medical Oncology Unit
[12] Hospital of Brindisi,Radiology Unit
[13] Hospital of Cuneo,Clinical Trial Center, Istituto Toscano Tumori
[14] Policlinico Sant’Orsola-Malpighi,undefined
[15] Azienda Ospedaliero-Universitaria Careggi,undefined
来源：
British Journal of Cancer | 2020年 / 123卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：26 / 32
页数：6
相关论文
共 50 条
  • [41] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Hisashi Tanaka
    Kageaki Taima
    Takeshi Morimoto
    Yoshihito Tanaka
    Masamichi Itoga
    Kunihiko Nakamura
    Akihito Hayashi
    Mika Kumagai
    Hideo Yasugahira
    Megumi Mikuniya
    Koichi Okudera
    Shingo Takanashi
    Sadatomo Tasaka
    BMC Cancer, 17
  • [42] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    BMC CANCER, 2017, 17
  • [43] Single-Arm Phase II Study of Nab-Paclitaxel for Patients with Chemorefractory Non-Small Cell Lung Cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S922 - S922
  • [44] A phase I/II study of Carboplatin plus Nab-Paclitaxel in PS 2 pts with advanced non-small-cell lung cancer
    Niwa, Takashi
    Nakashima, Kazuhisa
    Yoshioka, Hiroshige
    Iwamoto, Yasuo
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Mori, Keita
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations
    Baik, Christina
    Goulart, Bernardo
    Nguyen, Katherine
    Lee, Sylvia
    Eaton, Keith
    Chow, Laura
    Rodriguez, Cristina
    Santana-Davila, Rafael
    Wood, Rebecca
    Martins, Renato
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1227 - S1227
  • [46] The phase II study of nab-paclitaxel for relapsed NSCLC (NLCTG1302)
    Tanaka, Tomohiro
    Shoji, Satoshi
    Nozaki, Koichiro
    Miura, Satoru
    Watanabe, Satoshi
    Ishida, Takashi
    Tsukada, Hiroki
    Sato, Kazuhiro
    Hiura, Toru
    Okajima, Masaaki
    Ichikawa, Kosuke
    Abe, Tetsuya
    Tanaka, Hiroshi
    Yoshizawa, Hirohisa
    Kikuchi, Toshiaki
    ANNALS OF ONCOLOGY, 2018, 29
  • [47] A phase II trial of nab-paclitaxel and gemcitabine in patients with non-small cell lung cancer previously treated with platinum based chemotherapy
    Hatakeyama, Y.
    Tachihara, M.
    Kiriu, T.
    Hata, A.
    Nagano, T.
    Yamamoto, M.
    Kobayashi, K.
    Ohnishi, H.
    Katakami, N.
    Nishimura, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S102 - S102
  • [48] Trial in progress: A multicenter phase Ib/II study of pelcitoclax (APG-1252) in combination with paclitaxel in patients with relapsed/refractory small-cell lung cancer (R/R SCLC).
    Qin, Angel
    Kalemkerian, Gregory Peter
    Patel, Jyoti D.
    Mohindra, Nisha Anjali
    Carlisle, Jennifer W.
    Sands, Jacob
    He, Zhicong
    Winkler, Robert
    Liang, Zhiyan
    Hammock, Vakessa
    Bombelli, Riccardo
    Lu, Ming
    Xu, Yang
    Fu, Tommy
    Wang, Cunlin
    Yang, Dajun
    Zhai, Yifan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
    Gridelli, Cesare
    Chen, Tianlei
    Ko, Amy
    O'Brien, Mary E.
    Ong, Teng Jin
    Socinski, Mark A.
    Postmus, Pieter E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1445 - 1451
  • [50] Epirubicin combined with ifosfamide in relapsed or refractory small cell lung cancer (SCLC) patients
    Jacot, William
    Molinier, Olivier
    Colinet, Benoit
    Bozonnat, Marie-Cecile
    Quantin, Xavier
    Gervais, Radj
    Pujol, Jean-Louis
    ANNALS OF ONCOLOGY, 2006, 17 : 232 - 233
12345